SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Valeant Under Fire Again Following New York Times Article
October 5, 2015
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Pharm Country
Pfizer, Merck & Co., Valeant All Increase Prices of Existing Drugs
October 5, 2015
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Valeant Calms Employee Concerns of 20% Stock Drop As Congress Threatens Subpoena Over Drug Pricing
September 29, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Serial Acquirer Valeant Buys Synergetics USA in Sixth Deal of the Year (So Far)
September 2, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
AstraZeneca PLC Inks $445 Million Psoriasis Drug Pact With Valeant After Amgen Bows Out
September 1, 2015
 · 
2 min read
Job Trends
Valeant Doubles New Jersey Footprint on Heels of M&A Deals
August 26, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Valeant Acquires Female Sex Drive Drug Maker Sprout for $1 Billion
August 20, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Serial Acquirer Valeant Buys Egyptian Amoun for $800 Million
July 17, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
No Worries, Bayer Snubs Zoetis But Valeant Still Looking
July 2, 2015
 · 
4 min read
Load More
IN THE PRESS
Bausch Health Announces Closing Of Incremental Amendment To Its Existing Credit Agreement And Redemption Of Its 7.500% Senior Notes Due 2021
November 27, 2018
 · 
3 min read
Policy
Perrigo Confirms Patent Challenge for Generic Version of Jublia® Topical Solution 10%
October 1, 2018
 · 
5 min read
Business
Ekso Bionics Appoints Jack Glenn as Chief Financial Officer
August 13, 2018
 · 
4 min read
Drug Development
Strategic appointment expands Atlantic Healthcare executive team
August 8, 2018
 · 
7 min read
Policy
Virtus Thwarts Efforts of Bausch Health (formerly known as Valeant) to Push Lower Priced Competing Drugs off the Market
August 1, 2018
 · 
1 min read
Business
Bausch Health Companies Inc. Completes Name Change
July 13, 2018
 · 
3 min read
FDA
Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%
July 9, 2018
 · 
3 min read
FDA
FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion
June 18, 2018
 · 
3 min read
Bausch + Lomb Launches Soothe® Xtra Protection Preservative Free Lubricant Eye Drops
June 14, 2018
 · 
4 min read
Bausch + Lomb Introduces Ocuvite® Blue Light Eye Vitamins
June 12, 2018
 · 
4 min read
Load More